Eris Lifesciences fundamental analysis

ERIS

1321.1

30.50 (-2.26%)
Last updated on 13 Mar, 2026 | 15:46 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Eris Lifesciences Fundamentals

P/E Ratio

43.34

P/B Ratio

5.16

Div. Yield

0.54

Sector P/E

61.04

Sector P/B

2.7

Sec. Div. Yield

0.58

Eris Lifesciences Fundamentals is currently trading with a P/E Ratio of 43.34, compared to the sector average of 61.04. Its P/B Ratio stands at 5.16, while the sector’s is 2.7. In terms of returns, the stock offers a Dividend Yield of 0.54%, which is than the sector’s 0.58%.

Eris Lifesciences Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Eris Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost